PTX exhibits potent anti-inflammatory effects [31, 32], directly inhibits TNFα, and reduces inflammation in multiple preclinical models [33–35], chemotherapy-induced intestinal (CPT-11) and oral (5-FU) mucositis [36, 37]. Here, TNF is linked to mucositis.